Our findings do not contradict but rather complement these reports and indicate that both IG-DMR and MEG3 DMR methylation in conjunction with loss of imprinting, possible gene enhancer function, and expression of the entire 14q32 non-coding RNA cluster should be thoroughly studied in relation to osteosarcoma biology and outcome. This evidence concerns the gene MEG3 and osteosarcoma.